ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Breast Cancer Research And Treatment
Leyland-Jones, Brian B; Gray, Kathryn P KP; Abramovitz, Mark M; Bouzyk, Mark M; Young, Brandon B; Long, Bradley B; Kammler, Roswitha R; Dell'Orto, Patrizia P; Biasi, Maria Olivia MO; Thürlimann, Beat B; Harvey, Vernon V; Neven, Patrick P; Arnould, Laurent L; Maibach, Rudolf R; Price, Karen N KN; Coates, Alan S AS; Goldhirsch, Aron A; Gelber, Richard D RD; Pagani, Olivia O; Viale, Giuseppe G; Rae, James M JM; Regan, Meredith M MM; ,